Ascend Performance Materials to Exhibit Portfolio of Global Nylon 6,6 Technologies at Chinaplas 2016
Ascend Performance Materials will be showcasing its portfolio of Vydyne® nylon 6,6 products April 25-28 at Chinaplas 2016 (booth# N3B21), the largest plastics and rubber trade fair in Asia. Ascend, one of the world’s largest fully integrated producers of polyamide 66 (also known as nylon 6,6 or PA66), manufactures materials for automotive components, consumer goods, industrial products, textile goods, electrical and electronic components and carpet. Ascend’s Vydyne® PA66 fiber products are also widely used in air bags and tire cord.
“We are fully committed to the nylon 6,6 chain. It is our only business,” said Phil McDivitt, president, nylon at Ascend Performance Materials. “Our 60-plus years of nylon 6,6 technical expertise combined with our world-class operations and continued investments in our people, technologies and facilities make Ascend well-positioned to help customers grow in China and throughout Asia.”
Under the theme “inspiring everyday,” the company will highlight its material solutions at booth N3B21 at the Shanghai New International Expo Centre:
- New Vydyne® PA66 glass reinforced (15-35%) grades for automotive, electrical and electronic components – these grades are electrically neutral, halogen-free, offer high-flow and low-plate-out and are laser-markable.
- A new Vydyne® PA66 non-halogenated unreinforced FR (flame retardant) grade offers best-in-class RTI (Relative Temperature Index) performance. This FR grade is part of a major upgrade of Ascend’s solutions for electrical and electronic components.
- Vydyne® PA66 grades for automotive cooling system applications – these hydrolysis-resistant materials (HR grades) can meet hydrolysis-aging requirements of 3,000 hours at 120°C with improved property retention performance to exceed the increasing demands of global OEMs.
Members of Ascend’s global technology team will be available to discuss the 2015 SPE Innovation Award in the Body Exterior Category for a push-to-release fastener used in Ford Motor Company’s 2015 Mustang. This innovative part is made with Ascend’s Vydyne® 47H, a heat-stabilized, impact-modified grade of PA66.
Ascend also will display additional Vydyne® PA66 solutions:
- Cable ties and fasteners – New impact-modified, unreinforced grades are designed for high-performance applications and offer customers faster cycle times, higher heat resistance, weatherability and reduced plate out during processing.
- Food packaging – Vydyne® PA66-based FDA-compliant copolymers used in film packaging for food products, meat and fresh produce provide low permeation, act as a superior oxygen barrier and have higher heat resistance and puncture resistance compared to traditional polyamide solutions.
- No-Shock® antistatic fiber – Based on Ascend’s bi-component fiber technology, No-Shock® is available as filament (drawn and undrawn), staple fiber and sliver forms in a wide range of deniers. It provides inherent, permanent static dissipation, resists abrasion and is UV stable. No-Shock® is ideal for woven, knit and electrically embedded wearables as well as automotive applications such as seat covers, flooring, headliners and trunk liners. No-Shock® is easy to process with low usage rates, meets OEKO-TEX® Standard 100 and is REACH compliant.
“We continue to see increased demand for high-performance materials that enable our customers to innovate and design products that help them stay ahead of global trends as diverse as lighter-weight products to replace metal in automotive applications to products that improve food packaging to keep food fresher and retard spoiling,” said James Zhao, Ascend business director, Asia. “Our presence at Chinaplas provides us a platform to share information on the latest Vydyne® PA66 technologies that will help our customers accelerate their business.”
For more information on Ascend’s portfolio of PA66 solutions for automotive, electrical and electronic goods, cable ties and fasteners, consumer products and industrial applications, please visit us at Chinaplas booth #N3B21 or visit www.ascendmaterials.com.
NOTE TO EDITORS: ASCEND PERFORMANCE MATERIALS is a trademark of Ascend Performance Materials Operations LLC. This trademark has been registered in jurisdictions throughout the world, including the United States of America.
About Ascend Performance Materials
Ascend Performance Materials is a global premium provider of high-quality chemicals, fibers and plastics. Ascend is one of the world’s largest integrated PA66 producers, with its own in-house manufacturing facilities, ensuring total security of supply. Ascend’s product range has earned it an unequalled reputation for quality, innovative techniques and an enlightened approach to business that expands the horizons of possibility. With eight global locations and more than 3,200 people working at our sites around the world, Ascend has the inspiration, the expertise, the people and the attitude toward innovation to consistently deliver the right solution for customers.
Together, we’re making a difference.
Together, we’re inspiring everyday.
More information about Ascend can be found at www.ascendmaterials.com.
About SK Capital
SK Capital is a private investment firm with a disciplined focus on the specialty materials, chemicals and healthcare sectors. The firm’s purpose is to build strong and growing businesses that create substantial long-term economic value. SK utilizes its industry, operating and investment experience to identify opportunities to transform businesses into higher performing organizations with improved strategic positioning, growth and profitability as well as lower operating risk. SK Capital’s portfolio companies generate revenues of approximately $8 billion annually and employ approximately 9,000 people. The firm currently manages more than $1.5 billion of committed capital. For more information, please visit www.skcapitalpartners.com.
Ascend Performance Materials
Alison Jahn, + 713.210.9809
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Kite Announces Data From ZUMA-3 Study of KTE-C19 in Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia12.12.2017 00:30 | Pressemelding
Kite, a Gilead Company (Nasdaq: GILD), announced updated results from the ongoing Phase 1/2 ZUMA-3 study of KTE-C19, a CD19 chimeric antigen receptor T (CAR T) cell therapy, which is investigational for the treatment of adult patients with relapsed or refractory acute lymphoblastic leukemia (ALL). With a minimum of eight weeks of follow-up, 71 percent of ALL patients (n=17/24) who received a single infusion of KTE-C19 achieved complete tumor remission (complete remission (CR) or CR with incomplete hematological recovery). The ZUMA-3 study results were presented in an oral session at the Annual Meeting of the American Society of Hematology (ASH) in Atlanta. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171211005311/en/ ALL is an aggressive type of blood cancer which can also involve the lymph nodes, spleen, liver, central
NTT Communications Strengthens its DDoS Protection Services with New Detection Solution11.12.2017 23:00 | Pressemelding
NTT Communications Corporation (NTT Com), the global data and IP services arm of Fortune Global 500 telecom leader NTT (TYO: 9432), announced that it is expanding its Distributed Denial of Service Protection Services (DPS) with the addition of DPS Detect. This new solution can help customers detect potential attacks directed to their networks and initiate mitigations faster. DDoS attacks can strike at any time, potentially crippling network infrastructure and severely degrading the performance and reachability of a website or other IP-accessible assets. The expanded DPS suite of services will enable Global IP Network customers around the world to easily customize the level of service and assistance that best fits their needs. “Network security is one of the top priorities for our company,” said Michael Wheeler, executive vice president of the NTT Communications
Interactive Brokers Launches Bitcoin Futures Trading at the Start of Trading December 10th, 201711.12.2017 16:28 | Pressemelding
Interactive Brokers Group, Inc. (NASDAQ GS:IBKR), a global electronic brokerage firm, began offering clients the ability to trade bitcoin futures at the start of trading on the Cboe Futures Exchange (CFE) on Sunday night, December 10th, 2017. In addition to offering bitcoin futures from the CFE, under the ticker symbol GXBT, the company plans to offer bitcoin futures from the Chicago Mercantile Exchange (CME) at the scheduled start of trading December 18th using the symbol BRR. IBKR was there at the start of trading and its systems operated normally. “Interactive Brokers was on the buy side of the low print of 14,710,” said Thomas Peterffy, founder, Chairman and CEO of Interactive Brokers. “A Registered Investment Advisor on the Interactive Brokers platform purchased two March contracts in the first minute of trading.” As of 9:15am ET on Monday, the company said that
Boehringer Ingelheim Marks Great Progress in Immuno-oncology Research Partnerships in 201711.12.2017 13:00 | Pressemelding
2017 marks a year of significant advancement for Boehringer Ingelheim as it secured a range of external partnerships with the goal of transforming the lives of patients and winning the fight against cancer. External partnerships complement Boehringer Ingelheim’s two-pronged research strategy – investigating both cancer cell-directed therapies and immune cell-directed therapies. This multi-faceted approach offers the potential to bring innovative opportunities to the Boehringer Ingelheim oncology portfolio and novel therapies to patients. “Immuno-oncology is radically shifting the research and treatment landscape in oncology. We believe that the greatest success in difficult-to-treat cancers will be achieved with immuno-oncology and its combination with cancer cell directed therapy, which is why we are committing significant resources in both areas,” said Jonathon Sedgwick, Ph.D., Vice
Valence Advises SK Capital on Its Acquisition of ICL’s Fire Safety and Oil Additives Businesses11.12.2017 12:47 | Pressemelding
The Valence Group acted as lead financial advisor to SK Capital Partners on its announced acquisition of the Fire Safety and Oil Additives businesses of Israel Chemicals Ltd. (“ICL”) for approximately $1 billion. The transaction is expected to close during the first half of 2018. The Businesses, headquartered in St. Louis, Missouri, have global operations and are market leaders in each of their segments. The ICL Fire Safety business is a formulator and manufacturer of fire management chemicals. Its Phos-Chek fire retardants, Class A and B foams, and water enhancing gels are the world’s leading chemical solutions for managing wildland, military, industrial and municipal fires, and are used in partnership with fire management agencies across the globe. The ICL Oil Additives business provides high quality phosphorus pentasulfide used in the preparation of ZDDP-based lubricant additives, i
Smith & Nephew Announce European Launch of Handheld Imaging Technology Heralding a New Era of Evidence-Based Decision Making in Wound Care11.12.2017 10:18 | Pressemelding
Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces the European launch of MolecuLight i:X TM, the easy to use, handheld imaging device that instantly measures wound surface area and visualises the presence and distribution of potentially harmful bacteria in wounds.2,3 This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171211005434/en/ Currently wound assessments are made with the naked eye which can lack the accuracy required to most effectively guide clinical decision making.4 Using fluorescence, MolecuLight i:X quickly, safely, and easily visualises potentially harmful bacteria1,2,3 in wounds which may otherwise lack signs or symptoms of infection. It enhances a clinician’s ability to choose the right therapy, at the right time for their patient1,
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom